SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India - Quaterly Results

26 Jul 2024 Evaluate
The sales slipped to Rs. 4635.00 millions for the June 2024 quarter as against Rs. 5149.00 millions during the year-ago period.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 682.00  millions as against Rs. 810.00 millions reported during the corresponding quarter ended.Operating profit for the quarter ended June 2024 decreased to 1205.00 millions as compared to 1371.00 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202312 202212 % Var
Sales 4635.00 5149.00 -9.98 11959.00 12514.00 -4.44 28511.00 27701.00 2.92
Other Income 48.00 155.00 -69.03 113.00 413.00 -72.64 653.00 715.00 -8.67
PBIDT 1205.00 1371.00 -12.11 3459.00 3928.00 -11.94 8693.00 7759.00 12.04
Interest 4.00 7.00 -42.86 7.00 10.00 -30.00 17.00 17.00 0.00
PBDT 1011.00 1364.00 -25.88 2995.00 4096.00 -26.88 8854.00 9062.00 -2.30
Depreciation 90.00 91.00 -1.10 190.00 188.00 1.06 396.00 419.00 -5.49
PBT 921.00 1273.00 -27.65 2805.00 3908.00 -28.22 8458.00 8643.00 -2.14
TAX 239.00 463.00 -48.38 757.00 1194.00 -36.60 2426.00 2437.00 -0.45
Deferred Tax -33.00 -8.00 312.50 -115.00 -15.00 666.67 -7.00 -15.00 -53.33
PAT 682.00 810.00 -15.80 2048.00 2714.00 -24.54 6032.00 6206.00 -2.80
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 26.00 26.63 -2.36 28.92 31.39 -7.85 30.49 28.01 8.85

Sanofi India Share Price

3587.20 8.65 (0.24%)
21-Apr-2026 15:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.70
Dr. Reddys Lab 1220.00
Cipla 1232.60
Zydus Lifesciences 928.05
Lupin 2305.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×